Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Pietzsch

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Virology|May 31, 2013
Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse modelHenning Gruell, Stylianos Bournazos, Jeffrey V Ravetch, et al.
Cell|September 13, 2014
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activityStylianos Bournazos, Florian Klein, John Pietzsch, et al.
Journal of Virology|March 12, 2010
Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
The Journal of Experimental Medicine|August 4, 2010
Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitnessJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
Plos One|September 21, 2011
Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B virusesHugo Mouquet, Florian Klein, Johannes F Scheid, et al.
East African Journal of Public Health|November 10, 2011
Urban-rural estimation of hepatitis C virus infection sero-prevalence in north Central NigeriaJoseph C Forbi, John Pietzsch, Victoria O Olaleye, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
A mouse model for HIV-1 entryJohn Pietzsch, Henning Gruell, Stylianos Bournazos, et al.
The Journal of Experimental Medicine|July 25, 2012
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope proteinFlorian Klein, Christian Gaebler, Hugo Mouquet, et al.
Nature|October 1, 2010
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligationHugo Mouquet, Johannes F Scheid, Markus J Zoller, et al.
Nature|March 17, 2009
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individualsJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Virology|May 31, 2013
Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse modelHenning Gruell, Stylianos Bournazos, Jeffrey V Ravetch, et al.
Cell|September 13, 2014
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activityStylianos Bournazos, Florian Klein, John Pietzsch, et al.
Journal of Virology|March 12, 2010
Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
The Journal of Experimental Medicine|August 4, 2010
Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitnessJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
Plos One|September 21, 2011
Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B virusesHugo Mouquet, Florian Klein, Johannes F Scheid, et al.
East African Journal of Public Health|November 10, 2011
Urban-rural estimation of hepatitis C virus infection sero-prevalence in north Central NigeriaJoseph C Forbi, John Pietzsch, Victoria O Olaleye, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
A mouse model for HIV-1 entryJohn Pietzsch, Henning Gruell, Stylianos Bournazos, et al.
The Journal of Experimental Medicine|July 25, 2012
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope proteinFlorian Klein, Christian Gaebler, Hugo Mouquet, et al.
Nature|October 1, 2010
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligationHugo Mouquet, Johannes F Scheid, Markus J Zoller, et al.
Nature|March 17, 2009
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individualsJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Pageof 2